Skip to content

Performance and Safety Use of the Nanostructured Titanium Dental Implant KONTACT N

Multicenter, Prospective, Observational Study on the Performance and Safety Use of the Dental Implant KONTACT N in the Current Clinical Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03582657
Enrollment
164
Registered
2018-07-11
Start date
2019-02-04
Completion date
2022-01-13
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant, Dental Restoration, Edentulous Alveolar Ridge, Implant-supported Fixed Prosthesis

Keywords

nanostructured-implant, titanium implant, nano-roughness surface, hydrophilic surface, KONTACT N, BIOTECH DENTAL

Brief summary

A multicenter prospective observational study in which aim is to illustrate the clinical outcome of dental implants Kontact N; and the effects of its nanostructured surface on the osseointegration and secondary stability without increasing the rate of peri-implantitis. All the enrolled patients will be eligible for one or multiple implant-supported fixed restoration(s) according to the routine clinical practice and the manufacturer's instruction for use.

Interventions

DEVICEdental implant (KONTACT N)

Implant-supported prosthetic restoration

Sponsors

Biotech Dental
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Edentulous patient (partially or completely AND formerly, recently or just before implantation) requiring the placement of one (or more) dental implant (s) in maxillary or mandibular * Age ≥ 18 years * Good general health (ASA score between \[1-2\]) * Sufficient bone volume and quality (with or without bone graft) to support the implant * Non-opposition of the patient for the collection of his medical data as part of the study (delivery of a patient's sheet)

Exclusion criteria

1. Poor oral hygiene 2. Bruxism, parafunctional habits, occlusion disorders and / or temporomandibular joints 3. Infections and oral inflammation such as periodontitis, gingivitis 4. Patient with metabolic disorders (eg diabetes mellitus) or bone disease that may compromise peri-implant tissue healing 5. Heavy smoker (\> 10 cigarettes / day) 6. Patient with a pathology or immunosuppressive therapy such as chemotherapy, radiotherapy 7. Patient on prolonged steroid therapy 8. Titanium / titanium alloy allergy 9. Alcohol or drug abuse 10. Pregnant woman (or likely to be pregnant); or breastfeeding 11. Difficulty of medical follow-up patients with geographical, social or psychological constraints 12. Persons deprived of liberty or guardianship 13. Involuntary / patient refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Implant success rateup to 12 months post-implantationRate of implants still in function up to 12 months post-implantation and which fulfill all the predefined success criteria in the protocol.
Peri-implantitis rate12 months post-implantationPeri-implantitis is an inflammatory process affecting the tissues around the implant and causing loss of bone support (diagnosed by radiographic and clinical assessment).
Mean osseointegration periodFrom the implantation up to 12 monthsPeriod from which a direct structural and functional junction can be observed between the remodeled living bone and the implant surface (by clinical and radiographic assessment).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026